KZR-616 Shows Promise According to Results Reported at EULAR
Kezar Life Sciences announced positive results from the MISSION Phase 1 study testing the investigational KZR-616 as a treatment...
Read MoreHome
We are the world’s leading private funder of lupus research. Our goal: improve treatments while advancing lupus research toward a cure.
Why us?
Our funding is leading to key discoveries that are improving diagnosis and therapies, while enabling researchers to find the way toward prevention and ultimately a cure for lupus.
100%
of funds
go to support
research programs
500
Grants
fostering scientific
breakthroughs
$200
million
in support of
cutting-edge research
News and Events
Stelara® Effective Over One Year and Reduces Severe Flares
Results of two analyses from a Phase 2 study of Stelara® (ustekinumab) in lupus showed the drug’s effectiveness over...
Read MoreRituximab Effective for Maintenance Lupus Treatment Shows Study
June 13, 2019 A study published in Arthritis & Rheumatology found that rituximab was helpful as a maintenance therapy...
Read More
We’re building a strong and vibrant community for people living with lupus and their friends and family. Join us!
Watch these lupus warrior's stories
